Pressmeddelanden

Timo Hildén appointed Nukute’s Chairman of the Board of Directors

The Finnish medtech start-up renewed its Board to strengthen its strategic competence in dealing with the global medtech market. Nukute’s Board received a total of three new members. Alongside Hildén, Mr. Tommi Mäkelä as the representative of the Pharmacy Pension Fund (Finland) and Mr. Frans Wuite, CEO of Kompassi Gmbh. Johannes Gullichsen, Pekka Virtanen and Timo Laitinen continue as old...

Finnish medtech company Nukute successfully closes its series A funding round and goes after COVID-19 – receives a strategic three million euro investment from the Pharmacy Pension Fund (Finland)

Medtech company Nukute raised funding of €4.1 million on its series A round, €4.9 million with public funding included. The single largest investment came from the Pharmacy Pension Fund (Finland), that believed in Nukute’s business with an investment of €3.0 million. The company is moving forward with clinical trials and the obtaining of the CE marking for the added functionality to the Nukute...